Based on the information available, there is no specific guidance from the manufacturer of Cosentyx (secukinumab) regarding the waiting period between vaccination and starting the medication. The Cosentyx prescribing information does not mention vaccination as a consideration for initiating treatment [1]. However, the Centers for Disease Control and Prevention (CDC) recommends administering vaccines at least two weeks before starting immunosuppressive therapy, if possible [2].

It is always advisable to consult with a healthcare professional for personalized medical advice. They can provide guidance based on individual health circumstances and the most recent medical research.

Sources:
[1] Cosentyx (secukinumab) prescribing information. Novartis Pharmaceuticals Corporation. 2022. Available from: <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>.
[2] Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States. Centers for Disease Control and Prevention. 2022. Available from: <https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html>.

(Note: DrugPatentWatch.com was not used as a source for this answer, but it is a useful resource for information on drug patents and related topics.)